122 related articles for article (PubMed ID: 11550942)
1. Monitoring clinical trials with multiple arms.
Hellmich M
Biometrics; 2001 Sep; 57(3):892-8. PubMed ID: 11550942
[TBL] [Abstract][Full Text] [Related]
2. A group-sequential design for clinical trials with treatment selection.
Stallard N; Friede T
Stat Med; 2008 Dec; 27(29):6209-27. PubMed ID: 18792085
[TBL] [Abstract][Full Text] [Related]
3. Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches.
Müller HH; Schäfer H
Biometrics; 2001 Sep; 57(3):886-91. PubMed ID: 11550941
[TBL] [Abstract][Full Text] [Related]
4. An adaptive approach to implementing bivariate group sequential clinical trial designs.
Todd S
J Biopharm Stat; 2003 Nov; 13(4):605-19. PubMed ID: 14584711
[TBL] [Abstract][Full Text] [Related]
5. Closed testing procedures for group sequential clinical trials with multiple endpoints.
Tang DI; Geller NL
Biometrics; 1999 Dec; 55(4):1188-92. PubMed ID: 11315066
[TBL] [Abstract][Full Text] [Related]
6. Exact statistical inference for group sequential trials.
Lin DY; Wei LJ; DeMets DL
Biometrics; 1991 Dec; 47(4):1399-408. PubMed ID: 1786325
[TBL] [Abstract][Full Text] [Related]
7. On group sequential procedures under variance heterogeneity.
Hussein A; Carriere KC
Stat Methods Med Res; 2005 Apr; 14(2):121-8. PubMed ID: 15807147
[TBL] [Abstract][Full Text] [Related]
8. A group sequential Holm procedure with multiple primary endpoints.
Ye Y; Li A; Liu L; Yao B
Stat Med; 2013 Mar; 32(7):1112-24. PubMed ID: 23239078
[TBL] [Abstract][Full Text] [Related]
9. Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes.
Bratton DJ; Parmar MK; Phillips PP; Choodari-Oskooei B
Trials; 2016 Jul; 17(1):309. PubMed ID: 27369182
[TBL] [Abstract][Full Text] [Related]
10. Group sequential tests for bivariate response: interim analyses of clinical trials with both efficacy and safety endpoints.
Jennison C; Turnbull BW
Biometrics; 1993 Sep; 49(3):741-52. PubMed ID: 8241370
[TBL] [Abstract][Full Text] [Related]
11. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
Kim K; Boucher H; Tsiatis AA
Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
[TBL] [Abstract][Full Text] [Related]
12. On efficient two-stage adaptive designs for clinical trials with sample size adjustment.
Liu Q; Li G; Anderson KM; Lim P
J Biopharm Stat; 2012; 22(4):617-40. PubMed ID: 22651105
[TBL] [Abstract][Full Text] [Related]
13. Optimal conditional error functions for the control of conditional power.
Brannath W; Bauer P
Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
[TBL] [Abstract][Full Text] [Related]
14. Interim treatment selection using the normal approximation approach in clinical trials.
Shun Z; Lan KK; Soo Y
Stat Med; 2008 Feb; 27(4):597-618. PubMed ID: 17619239
[TBL] [Abstract][Full Text] [Related]
15. Adaptive sample size calculations in group sequential trials.
Lehmacher W; Wassmer G
Biometrics; 1999 Dec; 55(4):1286-90. PubMed ID: 11315085
[TBL] [Abstract][Full Text] [Related]
16. Interim treatment selection with a flexible selection margin in clinical trials.
Wu Y; Zhao PL
Stat Med; 2013 Jul; 32(15):2529-43. PubMed ID: 23212767
[TBL] [Abstract][Full Text] [Related]
17. Sequential conditional probability ratio tests for normalized test statistic on information time.
Xiong X; Tan M; Boyett J
Biometrics; 2003 Sep; 59(3):624-31. PubMed ID: 14601763
[TBL] [Abstract][Full Text] [Related]
18. Sequential methods and group sequential designs for comparative clinical trials.
Sébille V; Bellissant E
Fundam Clin Pharmacol; 2003 Oct; 17(5):505-16. PubMed ID: 14703713
[TBL] [Abstract][Full Text] [Related]
19. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
Schmidt R; Burkhardt B; Faldum A
Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
[TBL] [Abstract][Full Text] [Related]
20. Noninferiority Studies with Multiple New Treatments and Heterogeneous Variances.
Huang LC; Wen MJ; Cheung SH
J Biopharm Stat; 2015; 25(5):958-71. PubMed ID: 24918478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
